DECEIVING PATIENTS?

STATEMENT OF CO-INVENTORS
October 2009 – Budapest, Hungary

American Biosciences (Blauvelt, NY, USA) started to manufacture and distribute a wheat germ extract under the brand name AvéUltra. According to the claims AvéUltra is an improved form of Avemar, however, no scientific or otherwise experimental data are attached to support this assertion.

We, the co-inventors of Avemar, want to make a note that AvéUltra and Avemar are two different sets of compounds hence the qualities of Avemar can be attributed exclusively to Avemar therefore all references of AvéUltra to Avemar is scientifically unfounded, deceptive and abundantly unethical.

Avemar has been helping hundreds of thousands of patients suffering from cancer all over the world for more than ten years and proved to be safe, non toxic and advantageous. Several clinical studies investigated the various clinical benefits associated with Avemar treatment and the results were published in highly prestigious peer reviewed medical journals.

The Original Avemar is distributed in the US under the brand name ”Avé” and the manufacturing plant is under the surveillance of the authorities of the European Medical Agency. Deceiving patients suffering from a lethal disease with the promise of a safe and effective treatment is not only unethical and sinful but the clear confirmation of irresponsibility. We, as professors of medical sciences with over forty years of experience want to express our indignation and anger towards all parties who allow such practices to happen.

Erzsébet Rásó MSc PhD Senior Research Fellow Semmelweis University Budapest

Károly Lapis MD Dsc Professor Emeritus Member of the Hungarian Academy of Sciences Semmelweis University Budapest

Béla Szende MD DSc Professor Emeritus Semmelweis University Budapest